XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection (2022)

First Author: Gerber P

Attributed to: MRC Transition Support CSF Nicholas Matheson funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.90760

Publication URI: https://www.repository.cam.ac.uk/handle/1810/343348

Type: Journal Article/Review